vs
慧与（CITR）与FMC CORP（FMC）财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是慧与的3758.7倍（$1.1B vs $288.2K）。FMC CORP净利率更高（-158.8% vs -2751.2%，领先2592.3%）。慧与同比增速更快（169.3% vs -11.5%）。FMC CORP自由现金流更多（$631.1M vs $-1.5M）。过去两年慧与的营收复合增速更高（28.4% vs 8.6%）
慧与（HPE）是一家总部位于美国得克萨斯州斯普林的跨国信息技术企业，主打面向企业级客户的业务，业务领域涵盖服务器、存储、网络、容器化软件以及相关咨询与支持服务，在2018年财富美国500强总营收排名中位列第107名。
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
CITR vs FMC — 直观对比
营收规模更大
FMC
是对方的3758.7倍
$288.2K
营收增速更快
CITR
高出180.8%
-11.5%
净利率更高
FMC
高出2592.3%
-2751.2%
自由现金流更多
FMC
多$632.6M
$-1.5M
两年增速更快
CITR
近两年复合增速
8.6%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $288.2K | $1.1B |
| 净利润 | $-7.9M | $-1.7B |
| 毛利率 | -99.7% | 39.8% |
| 营业利润率 | -1470.3% | -130.8% |
| 净利率 | -2751.2% | -158.8% |
| 营收同比 | 169.3% | -11.5% |
| 净利润同比 | -1110.1% | -10457.1% |
| 每股收益（稀释后） | $-0.59 | $-13.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CITRFMC
| Q4 25 | — | $1.1B | ||
| Q3 25 | $288.2K | $542.2M | ||
| Q2 25 | $687.6K | $1.1B | ||
| Q1 25 | $969.4K | $791.4M | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $107.0K | $1.1B | ||
| Q2 24 | $198.7K | $1.0B | ||
| Q1 24 | $433.0K | $918.0M |
净利润CITRFMC
| Q4 25 | — | $-1.7B | ||
| Q3 25 | $-7.9M | $-569.3M | ||
| Q2 25 | $-11.9M | $66.7M | ||
| Q1 25 | $-10.9M | $-15.5M | ||
| Q4 24 | — | $-16.3M | ||
| Q3 24 | $-655.2K | $65.0M | ||
| Q2 24 | $-907.4K | $295.1M | ||
| Q1 24 | $-3.5M | $-2.7M |
毛利率CITRFMC
| Q4 25 | — | 39.8% | ||
| Q3 25 | -99.7% | 23.8% | ||
| Q2 25 | 46.0% | 38.7% | ||
| Q1 25 | 42.5% | 40.0% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | -30.0% | 36.3% | ||
| Q2 24 | 48.6% | 38.3% | ||
| Q1 24 | 79.2% | 37.0% |
营业利润率CITRFMC
| Q4 25 | — | -130.8% | ||
| Q3 25 | -1470.3% | -73.1% | ||
| Q2 25 | -438.8% | 12.0% | ||
| Q1 25 | -356.8% | 7.4% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | -524.4% | 12.7% | ||
| Q2 24 | -456.7% | 6.0% | ||
| Q1 24 | -608.9% | 8.1% |
净利率CITRFMC
| Q4 25 | — | -158.8% | ||
| Q3 25 | -2751.2% | -105.0% | ||
| Q2 25 | -1731.1% | 6.3% | ||
| Q1 25 | -1124.8% | -2.0% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -612.1% | 6.1% | ||
| Q2 24 | -456.7% | 28.4% | ||
| Q1 24 | -812.8% | -0.3% |
每股收益（稀释后）CITRFMC
| Q4 25 | — | $-13.77 | ||
| Q3 25 | $-0.59 | $-4.52 | ||
| Q2 25 | $-0.19 | $0.53 | ||
| Q1 25 | $-0.23 | $-0.12 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.11 | $0.52 | ||
| Q2 24 | $-0.02 | $2.35 | ||
| Q1 24 | $-0.04 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $584.5M |
| 总债务越低越好 | — | $3.4B |
| 股东权益账面价值 | $8.5M | $2.1B |
| 总资产 | $12.3M | $9.7B |
| 负债/权益比越低杠杆越低 | — | 1.62× |
8季度趋势，按日历期对齐
现金及短期投资CITRFMC
| Q4 25 | — | $584.5M | ||
| Q3 25 | — | $497.7M | ||
| Q2 25 | — | $438.2M | ||
| Q1 25 | — | $315.3M | ||
| Q4 24 | — | $357.3M | ||
| Q3 24 | — | $416.7M | ||
| Q2 24 | — | $471.5M | ||
| Q1 24 | — | $417.8M |
总债务CITRFMC
| Q4 25 | — | $3.4B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.4B | ||
| Q1 25 | — | $3.1B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.1B | ||
| Q1 24 | — | $3.1B |
股东权益CITRFMC
| Q4 25 | — | $2.1B | ||
| Q3 25 | $8.5M | $3.8B | ||
| Q2 25 | $2.2M | $4.4B | ||
| Q1 25 | $4.1M | $4.4B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | $2.8M | $4.6B | ||
| Q2 24 | $3.2M | $4.6B | ||
| Q1 24 | $3.8M | $4.3B |
总资产CITRFMC
| Q4 25 | — | $9.7B | ||
| Q3 25 | $12.3M | $12.1B | ||
| Q2 25 | $8.7M | $12.3B | ||
| Q1 25 | $9.1M | $11.8B | ||
| Q4 24 | — | $11.7B | ||
| Q3 24 | $4.9M | $12.2B | ||
| Q2 24 | $5.4M | $12.1B | ||
| Q1 24 | $5.3M | $12.0B |
负债/权益比CITRFMC
| Q4 25 | — | 1.62× | ||
| Q3 25 | — | 0.89× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | 0.69× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $657.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.5M | $631.1M |
| 自由现金流率自由现金流/营收 | -525.6% | 58.3% |
| 资本支出强度资本支出/营收 | 18.7% | 2.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-102.5M |
8季度趋势，按日历期对齐
经营现金流CITRFMC
| Q4 25 | — | $657.1M | ||
| Q3 25 | $-1.5M | $-184.2M | ||
| Q2 25 | $-1.2M | $65.9M | ||
| Q1 25 | $-713.9K | $-545.0M | ||
| Q4 24 | — | $427.9M | ||
| Q3 24 | $-551.3K | $159.5M | ||
| Q2 24 | $-424.9K | $292.2M | ||
| Q1 24 | $-343.7K | $-142.9M |
自由现金流CITRFMC
| Q4 25 | — | $631.1M | ||
| Q3 25 | $-1.5M | $-207.9M | ||
| Q2 25 | $-1.4M | $50.9M | ||
| Q1 25 | $-740.9K | $-576.6M | ||
| Q4 24 | — | $406.3M | ||
| Q3 24 | — | $143.8M | ||
| Q2 24 | — | $282.3M | ||
| Q1 24 | — | $-163.6M |
自由现金流率CITRFMC
| Q4 25 | — | 58.3% | ||
| Q3 25 | -525.6% | -38.3% | ||
| Q2 25 | -196.7% | 4.8% | ||
| Q1 25 | -76.4% | -72.9% | ||
| Q4 24 | — | 33.2% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | — | 27.2% | ||
| Q1 24 | — | -17.8% |
资本支出强度CITRFMC
| Q4 25 | — | 2.4% | ||
| Q3 25 | 18.7% | 4.4% | ||
| Q2 25 | 20.5% | 1.4% | ||
| Q1 25 | 2.8% | 4.0% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 0.0% | 1.0% | ||
| Q1 24 | 0.0% | 2.3% |
现金转化率CITRFMC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.45× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CITR
暂无分部数据
FMC
| Insecticides | $440.3M | 41% |
| Herbicides | $378.8M | 35% |
| Fungicides | $140.4M | 13% |
| Plant Health | $65.6M | 6% |
| Other | $45.0M | 4% |
